title: Approaches to demonstration of Ebola virus vaccine efficacy.
authors.affiliation: Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: philip.krause@fda.hhs.gov.
authors.forename: Philip R
authors.initials: PR
authors.lastname: Krause
authors.affiliation: Anti-infectives and Vaccines, European Medicines Agency, London, UK.
authors.forename: Marco
authors.initials: M
authors.lastname: Cavaleri
authors.affiliation: Clinical Evaluation Division-Vaccines, Health Canada, Ottawa, ON, Canada.
authors.forename: Gina
authors.initials: G
authors.lastname: Coleman
authors.affiliation: Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
authors.forename: Marion F
authors.initials: MF
authors.lastname: Gruber
mesh_terms: D015415:Biomarkers / Q000032:analysis*; D056808:Biostatistics / Q000379:methods; D046129:Ebola Vaccines / Q000008:administration & dosage / Q000276:immunology*; D029043:Ebolavirus / Q000276:immunology*; D019142:Hemorrhagic Fever, Ebola / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D046129:Ebola Vaccines